Advertisement
Advertisement

TNDM

TNDM logo

Tandem Diabetes Care, Inc.

19.45
USD
Sponsored
+1.42
+7.88%
Jun 04, 16:00 UTC -4
Closed
exchange

After-Market

19.36

-0.09
-0.46%

TNDM Earnings Reports

Positive Surprise Ratio

TNDM beat 22 of 42 last estimates.

52%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$260.40M
/
-$0.32
Implied change from Q1 26 (Revenue/ EPS)
+5.33%
/
+6.67%
Implied change from Q2 25 (Revenue/ EPS)
+8.19%
/
-33.33%

Tandem Diabetes Care, Inc. earnings per share and revenue

On May 07, 2026, TNDM reported earnings of -0.30 USD per share (EPS) for Q1 26, beating the estimate of -0.45 USD, resulting in a 33.80% surprise. Revenue reached 247.22 million, compared to an expected 245.95 million, with a 0.52% difference. The market reacted with a -16.19% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 22 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 260.40 million USD, implying an increase of 6.67% EPS, and increase of 5.33% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
FAQ
For Q1 2026, Tandem Diabetes Care, Inc. reported EPS of -$0.30, beating estimates by 33.8%, and revenue of $247.22M, 0.52% above expectations.
The stock price moved down -16.19%, changed from $18.47 before the earnings release to $15.48 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 22 analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.32 and revenue of $260.40M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement